- Home
- GDTC vs BTBD Comparison
GDTC vs BTBD Comparison
Compare GDTC & BTBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDTC | BTBD |
|---|---|---|
| Founded | 2018 | 1987 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4M | 11.4M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | GDTC | BTBD |
|---|---|---|
| Price | $0.94 | $1.72 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 19.4K | 16.6K |
| Earning Date | 04-24-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $14,823,472.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.68 | $1.03 |
| 52 Week High | $3.68 | $2.48 |
Technical Indicators
Market Signals| Indicator | GDTC | BTBD |
|---|---|---|
| Relative Strength Index (RSI) | 46.48 | 44.38 |
| Support Level | $0.76 | $1.53 |
| Resistance Level | $1.07 | $1.66 |
| Average True Range (ATR) | 0.12 | 0.14 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 41.71 | 21.62 |
Price Performance
Historical ComparisonAbout GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About BTBD BT Brands Inc.
BT Brands Inc operates and owns a fast-food restaurant called Burger Time. Its offerings include a variety of burgers and other affordable items, including sides and soft drinks. The company owns and operates Keegan's Seafood Grille (Keegan's), a dine-in restaurant located in Florida; Pie In The Sky Coffee and Bakery (PIE), located in Massachusetts; and Schnitzel Haus, a German-themed restaurant located in Florida. The company's revenues are derived from the sale of food and beverages at its restaurants.